Form 4: System1 CFO Awarded Stock Appreciation Rights Tied to EBITDA Milestones

Tridivesh Kidambi, CFO of System1, Inc., received 700,000 stock appreciation rights (SARs) under the company's 2024 plan, vesting upon achievement of specific EBITDA targets.

Summary

• Tridivesh Kidambi, the Chief Financial Officer of System1, Inc., was granted 700,000 stock appreciation rights (SARs) on July 1, 2024.
• These SARs were granted under the System1, Inc. 2024 Stock Appreciation Rights Plan, as amended.
• The exercise price of the SARs is $1.44, which was the Issuer's closing price on July 1, 2024.
• The SARs vest in four tranches, each representing 25% of the total award, upon System1 achieving trailing twelve month Adjusted EBITDA (TTM Adjusted EBITDA) milestones of $50 million, $60 million, $70 million, and $80 million after the grant date.
• Upon exercise, the Reporting Person will receive payment in either Class A Common Stock or cash, at the Issuer's discretion.
• The payment amount will be equal to the number of shares underlying the SARs being exercised multiplied by the excess of the fair market value of one share of Class A Common Stock on the exercise date over $1.44.

Sentiment

Score: 7

Explanation: The document is neutral to positive. It describes a standard executive compensation practice designed to incentivize performance. The vesting conditions tied to EBITDA targets suggest a focus on profitability.

Positives

• The SARs provide an incentive for the CFO to drive EBITDA growth.
• The vesting schedule aligns the CFO's interests with the company's financial performance.
• The SARs are granted under a formal plan, suggesting a structured approach to executive compensation.

Risks

• The SARs' value is dependent on System1's ability to achieve the specified EBITDA targets.
• If the EBITDA targets are not met, the SARs may not vest, potentially impacting the CFO's motivation.
• The value of the SARs is also subject to the market price of System1's Class A Common Stock.

Future Outlook

The document does not contain explicit forward-looking statements, but the SARs grant implies an expectation of future EBITDA growth.

Industry Context

Stock appreciation rights are a common form of equity compensation used to align executive incentives with shareholder value creation. Tying the vesting to EBITDA targets is a way to focus management on profitability.

Comparison to Industry Standards

• Many companies use stock options or restricted stock units (RSUs) as part of their executive compensation packages.
• SARs are less common than stock options or RSUs, but they offer the advantage of not requiring the executive to purchase the underlying stock.
• The specific EBITDA targets for vesting would need to be compared to System1's historical performance and industry benchmarks to assess their difficulty.

Stakeholder Impact

• Shareholders may view the SARs grant positively as it aligns management's interests with the company's financial performance.
• Employees may be motivated by the potential for company success and the achievement of EBITDA targets.

Key Dates